Lyka Labs First Quarter 2026 Earnings: EPS: ₹0.25 (vs ₹0.40 in 1Q 2025) - simplywall.st
3 days ago • Google News
Lyka Labs Limited (LYKALABS)
NSEINR 108.990.5%
Price Chart
Key Statistics
Market Cap
INR 3.88B
P/E Ratio
48.20
Revenue (TTM)
INR 1.38B
Volume
11.64K
52W High
INR 176.59
52W Low
INR 96.80
Dividend Yield
0.00%
Beta
0.64
Technicals
50-Day MA
114.173
200-Day MA
127.3447
52 Week High
176.59
52 Week Low
96.8
About LYKALABS
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients in India. The company manufactures and sells various .
Employees
499
Headquarters
Mumbai, India
CEO
Mr. Kunal Narendra Gandhi
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg